Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Britesite is an Ayurvedic ophthalmic formulation developed and marketed by Centaur Pharmaceuticals. It is a sterile eye drop solution containing a blend of 13 purified herbal extracts and honey, including *Rosa damascena*, *Curcuma longa*, *Glycyrrhiza glabra*, *Coriandrum sativum*, *Berberis aristata*, *Phyllanthus niruri*, *Piper longum*, *Terminalia bellirica*, *Albizia lebbeck*, *Ocimum sanctum*, *Butea frondosa*, and *Vitex negundo*. Britesite is indicated for soothing irritated, dry, and strained eyes, protecting the eyes from environmental pollutants (such as dust, smoke, and fumes), and supporting overall ocular health. The formulation possesses anti-inflammatory, antibacterial, antioxidant, and immunomodulatory properties, providing a cooling and soothing effect without causing stinging or burning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Britesite.